Treatment of Desmoid Fibromatosis With Arterial Embolization: Retrospective and Prospective Observational Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Desmoid fibromatoses are rare and locally aggressive mesenchymal tumors. The current scientific evidence regarding the efficacy and safety of the treatment of desmoid fibromatosis by arterial embolization is constituted by several retrospective and prospective studies. These studies report promising results through the use of chemoembolization, that is, arterial embolization using particles loaded with chemotherapy. Instead, the type of treatment we propose would consist of injection of embolizing material without the use of chemotherapy, based on the positive results we have consistently reported over the years on arterial embolization of musculoskeletal tumors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Healthy Volunteers: f
View:

• Patients of both sexes aged ≥ 12 years

• Fibromatosis demsoid symptomatic and in active phase (documented growth at last follow-ups)

• Patients not eligible for surgery or cryoablation

• Patients who have had embolization surgery for fibromatosis desmoide from 01/01/2023 to date and all new patients listed for this type of treatment.

• Signature of informed consent to the study

Locations
Other Locations
Italy
Istituto Ortopedico Rizzoli
RECRUITING
Bologna
Contact Information
Primary
Giancarlo Facchini, Medicine and Surgery
giancarlo.facchini@ior.it
+39 0516366836
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2029-02
Participants
Target number of participants: 20
Treatments
Performed embolization
Related Therapeutic Areas
Sponsors
Leads: Istituto Ortopedico Rizzoli

This content was sourced from clinicaltrials.gov